Clinical Trial of Eye Prophylaxis in the Newborn
NCT00000120 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2009-09-17
Summary
To compare the effectiveness of silver nitrate drops, erythromycin ointment, or no medication in preventing neonatal conjunctivitis caused by Chlamydia trachomatis and other eye infections.
To compare side effects of the two prophylactic agents.
Conditions
- Chlamydia Infections
- Ophthalmia Neonatorum
Interventions
- DRUG
-
Erythromycin Ointment
- DRUG
-
Silver Nitrate Drops
Sponsors & Collaborators
-
National Eye Institute (NEI)
lead NIH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Max Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1985-01-31
More Related Trials
-
The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period
NCT00892970 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis
NCT01877694 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis
NCT00629941 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Oral Azithromycin in the Treatment of Chlamydial Conjunctivitis
NCT01178762 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis
NCT01238783 ·Status: WITHDRAWN ·Phase: PHASE2
-
Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis
NCT03749317 ·Status: COMPLETED ·Phase: PHASE2
-
A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease
NCT01014078 ·Status: COMPLETED ·Phase: PHASE4
-
A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)
NCT01220258 ·Status: TERMINATED ·Phase: PHASE2
-
Does the Use of a Moisture Chamber Decrease the Incidence of Corneal Abrasions in Critically Ill Pediatric Patients?
NCT00129077 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis
NCT01089608 ·Status: COMPLETED ·Phase: PHASE2
-
Reducing Adenoviral Patient Infected Days
NCT02472223 ·Status: COMPLETED ·Phase: NA
-
Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in Rwanda
NCT01211327 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi-Center Study Evaluating the Safety of AC-170 0.24%
NCT02132169 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
NCT01532336 ·Status: COMPLETED ·Phase: PHASE2
-
AL-15469A for the Treatment of Bacterial Conjunctivitis
NCT00331916 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis
NCT02432807 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease
NCT02435914 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis
NCT00509873 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis
NCT00357019 ·Status: COMPLETED ·Phase: PHASE4
-
A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle in Subjects With Blepharitis (P08636)
NCT01269658 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis
NCT00656539 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle
NCT01881113 ·Status: COMPLETED ·Phase: PHASE3
-
A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Rewetting Drops in Subjects With History and Current Complaint of Contact Lens-Related Dry Eye (CLDE)
NCT01105624 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis
NCT00629980 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis
NCT00705159 ·Status: COMPLETED ·Phase: PHASE4